1.
Cleve Clin J Med
; 85(12): 931-937, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30526754
RESUMO
Research continues toward the goal of treating type 1 diabetes by replacing insulin-producing beta cells. Ideally, such treatment would be safe and long-lasting and would eliminate the need for subcutaneous insulin replacement. This article reviews the current state of beta-cell replacement through transplant of the whole pancreas or of islet cells. It also looks at the "bionic" pancreas and other future challenges.